IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas

A Olar, KM Wani, KD Alfaro-Munoz, LE Heathcock… - Acta …, 2015 - Springer
Diffuse gliomas are up till now graded based upon morphology. Recent findings indicate
that isocitrate dehydrogenase (IDH) mutation status defines biologically distinct groups of …

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas

A Olar, KM Wani, KD Alfaro-munoz… - Acta …, 2015 - search.proquest.com
Diffuse gliomas are up till now graded based upon morphology. Recent findings indicate
that isocitrate dehydrogenase (IDH) mutation status defines biologically distinct groups of …

[引用][C] IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas

A Olar, KM Wani, KD Alfaro-Munoz… - Acta …, 2015 - cir.nii.ac.jp
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III
diffuse gliomas | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データを …

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.

A Olar, KM Wani, KD Alfaro-Munoz… - Acta …, 2015 - europepmc.org
Diffuse gliomas are up till now graded based upon morphology. Recent findings indicate
that isocitrate dehydrogenase (IDH) mutation status defines biologically distinct groups of …

[PDF][PDF] IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas

A Olar, KM Wani, KD Alfaro‑Munoz, LE Heathcock… - 2015 - researchgate.net
Diffuse gliomas are up till now graded based upon morphology. Recent findings indicate
that isocitrate dehydrogenase (IDH) mutation status defines biologically distinct groups of …

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas

A Olar, KM Wani, KD Alfaro-Munoz… - Acta …, 2015 - go.gale.com
Diffuse gliomas are up till now graded based upon morphology. Recent findings indicate
that isocitrate dehydrogenase (IDH) mutation status defines biologically distinct groups of …

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas

A Olar, K Wani, K Diefes, L Heathcock, H van Thuijl… - Cancer Research, 2015 - AACR
Diffuse gliomas are up till now graded based upon morphology. Recent findings indicate
that isocitrate dehydrogenase (IDH) mutation status defines biologically distinct groups of …

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas

A Olar, KM Wani, KD Alfaro-Munoz… - Acta …, 2015 - pubmed.ncbi.nlm.nih.gov
Diffuse gliomas are up till now graded based upon morphology. Recent findings indicate
that isocitrate dehydrogenase (IDH) mutation status defines biologically distinct groups of …

[引用][C] IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas

A Olar, KM Wani, KD Alfaro-Munoz, LE Heathcock… - 2015 - repository.ubn.ru.nl
Diffuse gliomas are up till now graded based upon morphology. Recent findings indicate
that isocitrate dehydrogenase (IDH) mutation status defines biologically distinct groups of …

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas

A Olar, KM Wani, KD Alfaro-Munoz… - Acta …, 2015 - mdanderson.elsevierpure.com
Diffuse gliomas are up till now graded based upon morphology. Recent findings indicate
that isocitrate dehydrogenase (IDH) mutation status defines biologically distinct groups of …